Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease
This study has been completed.
Sponsor:
Stanford University
Collaborator:
Allergan
Information provided by (Responsible Party):
Rodney U Anderson, Stanford University
ClinicalTrials.gov Identifier:
NCT01421719
First received: August 19, 2011
Last updated: August 22, 2011
Last verified: August 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2011 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |